- Profile
- Personal Information
- Publications
Experts in Nephrology
Jessy J. Alexander Ibrahim Batal Ann Hagan Tanya Hoodbhoy Luis Alfredo Bent-Shaw Stephen Y Nakada Wade A Bushman David F Jarrard Patrick H McKenna David R Paolone Daniel H Williams IV E. Jason Abel Jyotsna Bhatnagar Sara Best Dale E Bjorling Reginald C Bruskewitz Tracy M Downs Andrew K Graf Dan R. Gralnek Sean P Hedican View MoreMs Hewitt was first elected to the Board of Novo Nordisk A/S in 2012 and has most recently been re-elected in March 2017. Her term as a board member expires in March 2018. In March 2017, the Board of Directors of Novo Nordisk A/S assessed that Ms Hewitt is regarded as an independent board member as defined in Section 3.2.1 of the Recommendations on Corporate Governance designated by Nasdaq Copenhagen. Ms Hewitt became a member of the Audit Committee at Novo Nordisk A/S in March 2012 and chairman of the Audit Committee in March 2015. In March 2017, the Board of Directors of Novo Nordisk A/S designated Ms Hewitt as financial expert as defined by the US Securities and Exchange Commission (SEC) and assessed that Ms Hewitt qualifies as independent pursuant to the US Securities Exchange Act. In addition, the Board of Directors of Novo Nordisk A/S assessed that Ms Hewitt has competences in accounting and auditing as required by the Danish Act on Approved Auditors and Audit Firms.
Medical devices